Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome
Authors
Keywords
-
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-06
DOI
10.1007/s00262-023-03562-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Exhaustion-associated cholesterol deficiency dampens the cytotoxic arm of antitumor immunity
- (2023) Chengsong Yan et al. CANCER CELL
- Cancer-associated fibroblast-derived extracellular vesicles mediate immune escape of bladder cancer via PD-L1/PD-1 expression
- (2023) Jun Ouyang et al. Endocrine Metabolic & Immune Disorders-Drug Targets
- Chemotherapy-induced PDL-1 expression in cancer-associated fibroblasts promotes chemoresistance in NSCLC
- (2023) Gayathri Heenatigala Palliyage et al. LUNG CANCER
- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- ICAM-1-mediated adhesion is a prerequisite for exosome-induced T cell suppression
- (2022) Wei Zhang et al. DEVELOPMENTAL CELL
- PD-L1 promotes myofibroblastic activation of hepatic stellate cells by distinct mechanisms selective for TGF-β receptor I versus II
- (2022) Liankang Sun et al. Cell Reports
- Mesothelial cell-derived antigen-presenting cancer-associated fibroblasts induce expansion of regulatory T cells in pancreatic cancer
- (2022) Huocong Huang et al. CANCER CELL
- Gemcitabine induces polarization of mouse peritoneal macrophages towards M1-like and confers antitumor property by inducing ROS production
- (2022) Aliva Prity Minz et al. CLINICAL & EXPERIMENTAL METASTASIS
- MIF confers survival advantage to pancreatic CAFs by suppressing interferon pathway‐induced p53‐dependent apoptosis
- (2022) Voddu Suresh et al. FASEB JOURNAL
- Atorvastatin Enhances the Efficacy of Immune Checkpoint Therapy and Suppresses the Cellular and Extracellular Vesicle PD-L1
- (2022) Eun-Ji Choe et al. Pharmaceutics
- Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non-small cell lung cancer
- (2022) Wenjun Mao et al. JCI Insight
- Enriched cancer stem cells, dense stroma, and cold immunity: Interrelated events in pancreatic cancer
- (2021) Keywan Mortezaee JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Mechanisms underlying low-clinical responses to PD-1/PD-L1 blocking antibodies in immunotherapy of cancer: a key role of exosomal PD-L1
- (2021) Zi Yin et al. Journal for ImmunoTherapy of Cancer
- Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer
- (2021) Katsuhiro Yoshikawa et al. BMC CANCER
- Mechanisms of PD-L1 Regulation in Malignant and Virus-Infected Cells
- (2021) Hadia Farrukh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mesenchymal Lineage Heterogeneity Underlies Non-Redundant Functions of Pancreatic Cancer-Associated Fibroblasts
- (2021) Erin J Helms et al. Cancer Discovery
- Statins Decrease Programmed Death-Ligand 1 (PD-L1) by Inhibiting AKT and β-Catenin Signaling
- (2021) Woo-Jin Lim et al. Cells
- Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma
- (2021) Minsu Kwon et al. CANCER LETTERS
- Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced tumor-associated fibrosis
- (2021) Debasish Mohapatra et al. LABORATORY INVESTIGATION
- Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer
- (2020) Ashenafi Bulle et al. Translational Oncology
- Modified FOLFIRINOX as a second-line therapy following gemcitabine plus nab-paclitaxel therapy in metastatic pancreatic cancer
- (2020) Masashi Sawada et al. BMC CANCER
- Challenges and Opportunities for Pancreatic Cancer Immunotherapy
- (2020) Adham S. Bear et al. CANCER CELL
- T-Cell Immunity in Pancreatic Cancer
- (2020) Reham Ajina et al. PANCREAS
- Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer
- (2020) Guo‐Qiang Zhang et al. CANCER SCIENCE
- Regulation of PD-L1 Expression by NF-κB in Cancer
- (2020) Fabrizio Antonangeli et al. Frontiers in Immunology
- Co-delivery of Gemcitabine and Simvastatin through PLGA polymeric nanoparticles for thetreatment of pancreatic cancer: In-vitro characterization, cellular uptake and pharmacokinetic studies
- (2019) Adeeba Jamil et al. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
- Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
- (2019) Xianjie Jiang et al. Molecular Cancer
- Reactive oxygen species modulate macrophage immunosuppressive phenotype through the up-regulation of PD-L1
- (2019) Cecilia Roux et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
- (2019) Mauro Poggio et al. CELL
- Cancer-associated fibroblasts-derived IL-8 mediates resistance to cisplatin in human gastric cancer
- (2019) Jing Zhai et al. CANCER LETTERS
- IFN-γ upregulates membranous and soluble PD-L1 in mesothelioma cells: potential implications for the clinical response to PD-1/PD-L1 blockade
- (2019) Maria Pia Pistillo et al. Cellular & Molecular Immunology
- IL-6/JAK1 pathway drives PD-L1 Y112 phosphorylation to promote cancer immune evasion
- (2019) Li-Chuan Chan et al. JOURNAL OF CLINICAL INVESTIGATION
- Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4+ and CD8+ T-Cells
- (2019) Laia Gorchs et al. Frontiers in Immunology
- IFN-gamma-induced PD-L1 expression in melanoma depends on p53 expression
- (2019) Alexander Thiem et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Mechanisms regulating PD-L1 expression on tumor and immune cells
- (2019) Shuming Chen et al. Journal for ImmunoTherapy of Cancer
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Second-line chemotherapy for the treatment of metastatic pancreatic cancer after first-line gemcitabine-based chemotherapy: a network meta-analysis
- (2018) Chiara Citterio et al. Oncotarget
- Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cells
- (2018) Kazumi Ebine et al. Scientific Reports
- Pancreatic fibroblast exosomes regulate survival of cancer cells
- (2017) S Suklabaidya et al. ONCOGENE
- The JAK/STAT pathway is involved in the upregulation of PD-L1 expression in pancreatic cancer cell lines
- (2017) Toshifumi Doi et al. ONCOLOGY REPORTS
- TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
- (2017) Florie Bertrand et al. Nature Communications
- Interleukin-15 stimulates natural killer cell-mediated killing of both human pancreatic cancer and stellate cells
- (2017) Jonas R.M. Van Audenaerde et al. Oncotarget
- Multifactorial regulators of tumor programmed death-ligand 1 (PD-L1) response
- (2017) R. Dixon Dorand et al. Translational Cancer Research
- IFNγ induces PD-L1 overexpression by JAK2/STAT1/IRF-1 signaling in EBV-positive gastric carcinoma
- (2017) Ji Wook Moon et al. Scientific Reports
- PD‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy
- (2016) Abul Azad et al. EMBO Molecular Medicine
- Chemotherapy-Induced Inflammatory Gene Signature and Protumorigenic Phenotype in Pancreatic CAFs via Stress-Associated MAPK
- (2016) P. A. Toste et al. MOLECULAR CANCER RESEARCH
- Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
- (2016) K E Richards et al. ONCOGENE
- Characterization and use of HapT1-derived homologous tumors as a preclinical model to evaluate therapeutic efficacy of drugs against pancreatic tumor desmoplasia
- (2016) Sujit Suklabaidya et al. Oncotarget
- Targeting of interleukin (IL)-17A inhibits PDL1 expression in tumor cells and induces anticancer immunity in an estrogen receptor-negative murine model of breast cancer
- (2016) Yun-Feng Ma et al. Oncotarget
- Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
- (2016) Leilei Tao et al. Scientific Reports
- Simvastatin Prevents and Reverses Depigmentation in a Mouse Model of Vitiligo
- (2015) Priti Agarwal et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- The future of immune checkpoint therapy
- (2015) P. Sharma et al. SCIENCE
- Gemcitabine triggers angiogenesis-promoting molecular signals in pancreatic cancer cells: Therapeutic implications
- (2015) Mohammad Aslam Khan et al. Oncotarget
- Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
- (2014) L. Rahib et al. CANCER RESEARCH
- TLR4 Activation Enhances the PD-L1–Mediated Tolerogenic Capacity of Colonic CD90+Stromal Cells
- (2014) Ellen J. Beswick et al. JOURNAL OF IMMUNOLOGY
- Origin of myofibroblasts in the fibrotic liver in mice
- (2014) K. Iwaisako et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma
- (2013) Abasi Ene–Obong et al. GASTROENTEROLOGY
- Novel Pancreatic Cancer Cell Lines Derived from Genetically Engineered Mouse Models of Spontaneous Pancreatic Adenocarcinoma: Applications in Diagnosis and Therapy
- (2013) María P. Torres et al. PLoS One
- Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment
- (2013) Michael H Kershaw et al. OncoImmunology
- Pancreatic Stellate Cells Radioprotect Pancreatic Cancer Cells through 1-Integrin Signaling
- (2011) T. S. Mantoni et al. CANCER RESEARCH
- CCK-2/gastrin receptor signaling pathway is significant for gemcitabine-induced gene expression of VEGF in pancreatic carcinoma cells
- (2011) Hiroki Kato et al. LIFE SCIENCES
- Simvastatin Improves Epithelial Dysfunction and Airway Hyperresponsiveness
- (2010) Tanveer Ahmad et al. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started